Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Digital Poster

From Molecular Signatures to Surgical Guidance: Cutting-Edge MRI in Brain Tumor Care

Back to the Program-at-a-Glance

From Molecular Signatures to Surgical Guidance: Cutting-Edge MRI in Brain Tumor Care
Digital Poster
Neuro B
Wednesday, 13 May 2026
Digital Posters Row D
16:55 - 17:50
Session Number: 563-06
No CME/CE Credit
This session features advanced quantitative MRI techniques and AI-driven innovations for brain tumor diagnosis and characterization, including CEST MRI for glioma grading, molecular prediction of IDH mutations, and high-field spectroscopy. Presentations showcase clinical automation tools such as LLM-based BT-RADS scoring, deep learning for spectroscopy analysis, and intraoperative 3D MRI guidance for surgical planning.
Skill Level: Intermediate

  Figure 563-06-001.  Improved glioma grading and IDH mutation status prediction with QUASS-based AREX analysis using CEST MRI
Jiahui Xie, Yinwei Ying, Ruibin Liu, Dong Liang, Bo Yin, Yin Wu
Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
Impact: The proposed quasi-steady-state (QUASS)-based apparent exchange-dependent relaxation (AREX) analysis demonstrated superior performance in glioma grading and IDH mutation status prediction compared to conventional APT measurements, enabling more accurate tumor characterization in clinical practice.
  Figure 563-06-002.  Does APT-weighted CEST MRI depend on protein and amide proton content in human brain tumor?
Yulun Wu, Rick Bezemer, Tobias Wood, Thomas Booth, Matthew Benger, Caitlin O'Brien, Keyoumars Ashkan, Fatemeh Arzanforoosh, Amina Avan, Lennard Dekker, Sophie Veldhuijzen van Zanten, Ilanah Pruis, Eelke Bos, Joost Schouten, Arnaud Vincent, Marion Smits, Theo Luider, Esther Warnert
Erasmus MC, Rotterdam, Netherlands
Impact: Through proteomic analysis of 65 image-guided biopsies we disprove the common hypothesis that increased amide proton transfer (APT) weighted CEST MRI signal in brain tumors in humans is related to local increases in protein content.
  Figure 563-06-003.  Quantitative Sodium MRI for Pituitary Neuroendocrine Tumors: A Preliminary 3T Study
Peng Liu, Naying He, Jinyuan Weng, Peng Wu, Zhongping Zhang, Fuhua Yan
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Impact: 23Na MRI may provide new metabolic biomarkers for PitNET characterization, enabling improved diagnosis and individualized therapy. Larger studies are needed to validate its potential for clinical application and prognostic assessment.
  Figure 563-06-004.  Automating BT-RADS Scoring and Structured MRI Reporting in Post-Treatment Glioma Using Large Language Models
Zhi Liu
Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China
Impact: This study demonstrates that LLMs can automate BT-RADS scoring, enhance reporting consistency, and reduce clinical workload, facilitating broader adoption of standardized glioma follow-up in routine practice.
  Figure 563-06-005.  Assessment of Glioma Solid Stress Using MR Elastography and 3D Volumetric MRI
Noah Jaitner, Mehrgan Shahryari, Jakob Schattenfroh, Tom Meyer, Hossein Aghamiry, Jakob Ludwig, Jakob Jordan, Anastasia Janas, Anna Morr, Biru Huang, Boshra Shams, Thomas Picht, Gueliz Acker, Tobias Schaeffter, Jing Guo, Ingolf Sack
Charité – Universitätsmedizin Berlin, Berlin, Germany
Impact: This study combines multifrequency MRE with 3D volumetric MRI to quantify solid stress exerted by brain tumors to surrounding tissue. Elevated excess stress correlated with shorter survival time in patients with glioma.
  Figure 563-06-006.  A Semi-Automatic Methodology For Accurate Estimation of Residual Tumor Volume In Postoperative GBM Patients
Mohammad Tufail Sheikh, Ankit Kandpal, Rakesh Singh, Rakesh Kumar Gupta, Anup Singh
Indian Institute of Technology, Delhi, India
Impact: The study introduces a methodology for residual tumor volume evaluation using pre-operative, immediate post-operative, and two-week follow-up multiparametric MRI. Accurate residual tumor estimation could facilitate targeted treatment planning, leading to improved prognosis and enhanced overall survival in glioblastoma patients.
  Figure 563-06-007.  Magnetic resonance imaging-based habitat, intra-, and peritumoral radiomic model for preoperative prediction of IDH Mutation
Qun-hui Ouyang, Rutong Pan, Ping Liu
The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China
Impact: This study establishes a clinically applicable, MRI-based fusion model integrating habitat and peritumoral radiomics to noninvasively predict IDH mutation in glioma. It advances precision molecular stratification, offering new insights into peritumoral biology and promoting individualized surgical and therapeutic decision-making.
  Figure 563-06-008.  Predicting IDH Mutation and 1p/19q Codeletion Status in Non-enhancement and Hypo-enhancement Adult-type Diffuse Glioma Using
Liqiang Zhang
The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
Impact: This study investigated the effectiveness of LLMs with image-to-text technology to predict IDH mutation and 1p/19q codeletion status in non-enhancement and hypo-enhancement adult-type diffuse glioma. Furthermore, the human expert-defined prior knowledge is incorporated to enhance the performance of LLMs.
  Figure 563-06-009.  Comparison of Metabolite Estimation Approaches with MRSI at 7T
Ahmet Azgın, Barbara Dymerska, Martina Callaghan, Philipp Lazen, Sagar Acharya, Sara Huskic, Haniye Shayeste, Simon Robinson, Lukas Hingerl, Bernhard Strasser, Juliane Hennenberg, Matthias Preusser, Thomas Roetzer-Pejrimovsky, Wolfgang Bogner, Karl Rössler, Georg Widhalm, Gilbert Hangel
Medical University of Vienna, Vienna, Austria
Impact: Metabolic imaging using internal water referencing through quantitative maps could allow us to get subject based concentration estimates in the brain, and help us image pathologies like gliomas. This would allow better intra- and inter - subjects analysis.
  Figure 563-06-010.  Diagnostic Efficacy of Quantitative Analysis Using pCASL & DKI Sequences + WM Skeleton to Distinguish Glioma TR from PsP
Peiquan Liu, Yujie Chen, xiaoxiao zhang, Yuanhao Li, Jiaxuan Zhang, Wenzhen Zhu
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1095, Wuhan, China
Impact: This study addresses a critical unmet clinical need by leveraging white matter fiber skeleton-based quantitative parameters (WMTI_AWF, FW_MD) to enhance the diagnostic precision of distinguishing glioma TR from PsP, resolving a long-standing clinical dilemma in postoperative glioma management.
  Figure 563-06-011.  Ferumoxytol-Enhanced MRI Maps Macrophage-Associated Inflammation in Gliomas and Vestibular Schwannomas
James Breese, Rainer Hinz, Daniel Lewis, William Lloyd, Andrew Tyler, Ka-loh Li, Xiaoping Zhu, Bandar Alfaifi, Alan Jackson, Andrew King, David Coope
University of Manchester, Manchester, United Kingdom
Impact: Ferumoxytol-enhanced MRI enables non-invasive mapping of macrophage activity, uncovering a unique insight into tumour immune processes, beyond conventional contrast-enhancing methods. This biomarker could guide patient selection for immunotherapy and a provide a deeper understanding into the mechanisms of tumour progression.
  Figure 563-06-012.  2-Hydroxyglutarate-edited Deep Learning Complex Frequency and Phase Correction
Hanna Bugler, Gerd Melkus, Thanh Nguyen, Roberto Souza, Ashley Harris
University of Calgary, Calgary, Canada
Impact: Complex frequency and phase correction (FPC) preprocessing of 2-hydroxyglutarate MRS data improved spectrum quality compared to traditional FPC. Increased 2-hydroxyglutarate MRS quality can improve the accuracy and reliability of 2-hydroxyglutarate as a biomarker for the non-invasive prognosis of gliomas.
  Figure 563-06-013.  Pathology-Controlled Brain MRI Synthesis Using Conditional Wavelet Diffusion Model
Fei Tan, Ashok Vardhan Addala, Xucheng Zhu, Bruno Astuto, Ravi Soni
GE HealthCare, San Ramon, United States of America
Impact: Our approach preserves real lesions while increasing diversity of 3D brain MR images with conditional wavelet diffusion model. Interactive lesion deformation enables controlled pathology generation, supporting clinically relevant data augmentation for vision and vision-language tasks in data-scarce scenarios.
  Figure 563-06-014.  Intraoperative 3D quantitative magnetic resonance imaging in paediatric brain tumor surgery
Per Nyman, Frederik Testud, Anna Ljusberg, Oscar Snödahl, Rafael Holmgren, Emma Nordh, Ida Blystad, Peter Lundberg, Anders Tisell
Linköping University, Linköping, Sweden
Impact: We implemented a 3D qMRI method for improving tumor delineation in intra-operative pediatric brain tumor surgery. Results showed that relaxation rates were accurately measured, and transverse relaxation rates were increased in intra-operative settings probably due to anesthetic drugs.
  Figure 563-06-015.  Value of NODDI, DKI, DTI in the Preoperative Differentiation of ACTH-Secreting and Non-ACTH-Secreting Pituitary macroadenomas
Yiyue Shi, linkun wang, Wei Wei, 亚平 吴, Yan Bai, Meiyun Wang
Henan University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, China
Impact: This study facilitates preoperative differentiation between corticotroph and non-corticotroph macroadenomas, enabling personalized treatment stratification and potentially avoiding unnecessary surgery.
  Figure 563-06-016.  A prospective study - constructing a Weibull model for survival of IDH-1 wild-type GBM patients based on multimodal MRI
huaze xi
The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
Impact: This study is the first to use the multi-parameter Weibull hazard ratio model to predict the survival of GBM patients, and make a relatively accurate prediction of the nonlinear death time within two years.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine